Natural Capsules Limited (NATCAPSUQ.BO)
INR 217.95
(2.81%)
INR 217.95
(2.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.47 Billion INR | 5.13% |
| 2022 | 1.4 Billion INR | 72.84% |
| 2021 | 812.96 Million INR | 132.65% |
| 2020 | 349.43 Million INR | 83.3% |
| 2019 | 190.63 Million INR | 8.03% |
| 2018 | 176.46 Million INR | 5.46% |
| 2017 | 167.32 Million INR | -3.68% |
| 2016 | 173.72 Million INR | -20.01% |
| 2015 | 217.19 Million INR | 33.34% |
| 2014 | 162.88 Million INR | -2.66% |
| 2013 | 167.33 Million INR | -14.27% |
| 2012 | 195.2 Million INR | 6.03% |
| 2011 | 184.1 Million INR | -21.09% |
| 2010 | 233.31 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 1.4 Billion INR | 0.0% |
| 2023 Q4 | 1.47 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.47 Billion INR | 5.13% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.21 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.4 Billion INR | 72.84% |
| 2022 Q4 | 1.4 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 812.96 Million INR | 0.0% |
| 2021 FY | 812.96 Million INR | 132.65% |
| 2021 Q2 | 633.5 Million INR | 40.19% |
| 2021 Q1 | 451.9 Million INR | 29.32% |
| 2020 Q3 | 211 Million INR | 22.6% |
| 2020 Q2 | 172.1 Million INR | 0.0% |
| 2020 Q4 | 349.43 Million INR | 65.61% |
| 2020 FY | 349.43 Million INR | 83.3% |
| 2019 Q4 | 190.63 Million INR | -5.35% |
| 2019 FY | 190.63 Million INR | 8.03% |
| 2019 Q2 | 191.8 Million INR | 0.0% |
| 2019 Q3 | 201.4 Million INR | 5.01% |
| 2018 FY | 176.46 Million INR | 5.46% |
| 2018 Q4 | 176.46 Million INR | -10.69% |
| 2018 Q3 | 197.6 Million INR | 27.03% |
| 2018 Q2 | 155.55 Million INR | 0.0% |
| 2017 Q2 | 165.8 Million INR | 0.0% |
| 2017 FY | 167.32 Million INR | -3.68% |
| 2017 Q4 | 167.32 Million INR | 0.0% |
| 2016 Q4 | 172.47 Million INR | 0.0% |
| 2016 FY | 173.72 Million INR | -20.01% |
| 2016 Q2 | 174.17 Million INR | 0.0% |
| 2015 FY | 217.19 Million INR | 33.34% |
| 2015 Q4 | 217.19 Million INR | 0.0% |
| 2015 Q2 | 167.51 Million INR | 0.0% |
| 2014 Q2 | 194.05 Million INR | 0.0% |
| 2014 FY | 162.88 Million INR | -2.66% |
| 2014 Q4 | 162.88 Million INR | 0.0% |
| 2013 Q4 | 167.33 Million INR | 0.0% |
| 2013 Q2 | 177.44 Million INR | 0.0% |
| 2013 FY | 167.33 Million INR | -14.27% |
| 2012 Q4 | 195.2 Million INR | 0.0% |
| 2012 FY | 195.2 Million INR | 6.03% |
| 2011 Q4 | 184.1 Million INR | 0.0% |
| 2011 FY | 184.1 Million INR | -21.09% |
| 2010 Q4 | 233.31 Million INR | 0.0% |
| 2010 FY | 233.31 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.66 Billion INR | 11.097% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -827.872% |
| Bacil Pharma Limited | 1.12 Million INR | -130742.25% |
| BDH Industries Limited | 312.53 Million INR | -372.654% |
| Beryl Drugs Limited | 85.63 Million INR | -1624.986% |
| Cian Healthcare Limited | 1.03 Billion INR | -42.815% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -69317.716% |
| Concord Drugs Limited | 249.88 Million INR | -491.153% |
| Deccan Health Care Limited | 111.33 Million INR | -1226.803% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -1154.796% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -813.696% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -648.435% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -5647.657% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -16550.237% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -632.772% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -48.261% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 13.929% |
| Makers Laboratories Limited | 569.18 Million INR | -159.533% |
| Medi-Caps Limited | 63.01 Million INR | -2244.181% |
| MedPlus Health Services Limited | 14.27 Billion INR | 89.651% |
| Panchsheel Organics Limited | 340.2 Million INR | -334.215% |
| Parnax Lab Limited | 1.17 Billion INR | -26.18% |
| Trident Lifeline Limited | 331.26 Million INR | -345.934% |
| Parmax Pharma Limited | 117.56 Million INR | -1156.475% |
| Patidar Buildcon Limited | 25.57 Million INR | -5676.666% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -743.315% |
| Phaarmasia Limited | 211.49 Million INR | -598.46% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -852.639% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -493949.833% |
| Smruthi Organics Limited | 485.72 Million INR | -204.128% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -3419.511% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 13.825% |
| Transchem Limited | 6.72 Million INR | -21882.277% |
| Trinity League India Limited | 876 Thousand INR | -168531.164% |
| Tyche Industries Limited | 101.64 Million INR | -1353.359% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -406.803% |
| Vivanza Biosciences Limited | 148.63 Million INR | -893.877% |
| PRAVEG LIMITED | 767.53 Million INR | -92.461% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 1.558% |
| Sunil Healthcare Limited | 902.83 Million INR | -63.62% |
| Syschem (India) Limited | 1.07 Billion INR | -37.964% |
| Zenith Healthcare Limited | 24.03 Million INR | -6046.074% |
| Zenlabs Ethica Limited | 301.35 Million INR | -390.191% |
| Mercury Laboratories Limited | 171.18 Million INR | -762.911% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -6937.68% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2653.572% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -47.084% |
| Roopa Industries Limited | 493.08 Million INR | -199.584% |
| PANJON LTD. | 25.38 Million INR | -5719.679% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -608.694% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -9761.867% |
| Anuh Pharma Limited | 1.54 Billion INR | 4.364% |
| Crestchem Limited | 23.94 Million INR | -6068.66% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -10919.836% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1149.511% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 20.635% |
| Trimurthi Limited | 101.36 Thousand INR | -1457288.516% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -631.386% |
| Norris Medicines Limited | 278.17 Million INR | -431.039% |
| Veerhealth Care Limited | 62.78 Million INR | -2252.993% |
| Lactose (India) Limited | 536.39 Million INR | -175.395% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -77.305% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -30.622% |
| Gennex Laboratories Limited | 535.21 Million INR | -176.004% |
| Denis Chem Lab Limited | 289.82 Million INR | -409.695% |
| Colinz Laboratories Limited | 24.1 Million INR | -6028.227% |
| Godavari Drugs Limited | 957.86 Million INR | -54.219% |
| Zenotech Laboratories Limited | 156.64 Million INR | -843.012% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -202.479% |
| Bharat Parenterals Limited | 2.65 Billion INR | 44.392% |
| Coral Laboratories Limited | 281.83 Million INR | -424.132% |
| Evoq Remedies Limited | 116.23 Million INR | -1170.914% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -39.669% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 27.695% |
| Auro Laboratories Limited | 433.09 Million INR | -241.08% |